Because ILC in general lacks expression of human epidermal growth factor receptor 2 (Her2; a marker present in some breast cancer subtypes for which specific treatments are available), there is currently no targeted intervention for metastatic lobular breast cancer. The gene discussed is ERBB2; the disease is breast carcinoma.